0001051339-21-000002.txt : 20210414 0001051339-21-000002.hdr.sgml : 20210414 20210414114924 ACCESSION NUMBER: 0001051339-21-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210414 DATE AS OF CHANGE: 20210414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENARROCH GEORGES CENTRAL INDEX KEY: 0001051339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50390 FILM NUMBER: 21824970 MAIL ADDRESS: STREET 1: 49 AVENUE FOCH CITY: PARIS STATE: I0 ZIP: 75116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kyto Technology & Life Science, Inc. CENTRAL INDEX KEY: 0001164888 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651086538 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 13050 PALOMA ROAD CITY: LOS ALTOS HILLS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-204-7896 MAIL ADDRESS: STREET 1: 13050 PALOMA ROAD CITY: LOS ALTOS HILLS STATE: CA ZIP: 94022 FORMER COMPANY: FORMER CONFORMED NAME: KYTO BIOPHARMA INC DATE OF NAME CHANGE: 20030912 FORMER COMPANY: FORMER CONFORMED NAME: B TWELVE INC DATE OF NAME CHANGE: 20020111 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-03-16 0 0001164888 Kyto Technology & Life Science, Inc. KBPH 0001051339 BENARROCH GEORGES 49 AVENUE FOCH PARIS I0 75116 FRANCE 1 0 0 0 Common Shares 2021-03-16 4 M 0 181250 0.033 A 181250 D Non-qualified Stock Option (Right to Buy) 0.033 2021-03-16 4 M 0 181250 0.033 D 2021-03-16 2021-12-16 Common Shares 181250 18750 D George Benarroch exercised 181,250 options to purchase 181,250 common shares at $0.033 per share. Company confirmed option exercise with share issuance to be completed when company reorganization and name changed completed Effective April 5, 2021, Georges Benarroch ceased to be a Director of the Company. Comindus Finance Corp., of which Georges Benarroch is an Officer and Director, is an insider with more than 10% shareholding of the Company. Georges Benarroch 2021-04-14